Will using the power of the executive branch bring healthcare prices down? Recent events suggest otherwise.
The FDA’s influence in the prescription drug market remains the largest obstacle to deregulation.
In the print edition of the latest issue of National Review, staff writer David French has a sobering article describing how the Veterans Health Administration is overdosing veterans on prescription drugs. A veteran himself, French has plenty of anecdotes about his buddies: They couldn’t sleep, so they had to take Ambien. They were depressed,...
Read More »